By Manasi | Monday: Research Reads Reading time: approx. 6 minutes
Mindfulness has had an unusual journey.
It began as a contemplative practice rooted in Buddhist tradition, entered Western clinical psychology in the late 1970s through Jon Kabat-Zinn’s work on stress reduction, accumulated an impressive body of research evidence, became widely recommended by clinicians and health services, and then somewhere along the way got absorbed into the wellness industry and turned into a product.
Mindfulness apps, mindfulness colouring books, mindfulness corporate retreats, mindfulness as a solution to burnout caused by the same systems that sell the mindfulness products. The gap between the clinical concept and the cultural phenomenon has become, at times, quite wide.
This creates a genuine problem for anyone trying to evaluate it clearly. Is mindfulness a rigorously evidenced psychological intervention? Yes, in important and specific ways. Is it a universal solution to psychological distress? No and the research, read carefully, does not claim that it is. The honest answer, as with most things in clinical psychology, is considerably more nuanced than either its advocates or its critics tend to suggest.
This post is an attempt at that nuance.
What you will learn in this post
- Where mindfulness came from and how it entered clinical psychology
- What the research evidence actually shows and for which presentations
- What mindfulness is doing neurologically
- The genuine limitations and what the critics get right
- What this means practically
From Buddhist practice to clinical intervention
The story of mindfulness in Western psychology begins substantially with Jon Kabat-Zinn, a molecular biologist and meditation practitioner who developed Mindfulness-Based Stress Reduction (MBSR) at the University of Massachusetts Medical School in 1979. His innovation was to take the core attentional practices of Buddhist meditation particularly the cultivation of sustained, non-judgmental present-moment awareness and translate them into a secular, structured eight-week programme that could be studied empirically and delivered in medical settings.
MBSR was initially developed for patients with chronic pain and stress-related conditions. Its early results were promising enough to attract research attention, and the following decades saw a significant expansion of the evidence base.
The most influential clinical adaptation came in the late 1990s, when Zindel Segal, Mark Williams, and John Teasdale developed Mindfulness-Based Cognitive Therapy (MBCT) a programme combining mindfulness practices with elements of cognitive therapy, specifically designed to prevent relapse in people with recurrent depression. The research on MBCT’s effectiveness for relapse prevention has been among the most compelling in the mindfulness literature, and it led to MBCT being recommended by NICE in the UK as a treatment for recurrent depression.
What the research actually shows
The evidence base for mindfulness is large thousands of published studies, numerous meta-analyses, and a growing body of neuroimaging research. The question is not whether there is evidence, but what it actually supports.
Depression. The evidence for MBCT in preventing relapse in people with three or more previous depressive episodes is robust. A landmark meta-analysis by Kuyken and colleagues, published in JAMA Internal Medicine, found that MBCT reduced relapse rates by roughly 30% compared to usual care in this population. This is a meaningful clinical finding. The evidence for mindfulness as an acute treatment for current depression helping people who are currently depressed is less strong than for relapse prevention.
Anxiety. Mindfulness-based interventions show consistent positive effects for generalised anxiety, social anxiety, and health anxiety across multiple studies. The mechanisms are thought to include increased tolerance of uncertainty, reduced experiential avoidance, and improved capacity to observe anxious thoughts without being entirely swept up in them.
Chronic pain. This is where MBSR was initially developed, and the evidence remains meaningful. Mindfulness does not eliminate pain it changes the relationship to pain, reducing the secondary suffering that comes from catastrophising, resistance, and the anticipation of future pain. Research consistently shows reductions in pain-related distress and improved functioning, even when the pain itself does not change.
Stress and burnout. The evidence for mindfulness in reducing psychological stress is broadly positive, though effect sizes in general population samples tend to be modest. The meaningful finding here is not that mindfulness eliminates stress it is that it appears to change how people relate to stressful experience, reducing reactivity and improving recovery.
What the evidence does not support is the claim that mindfulness is universally beneficial for all people in all contexts. For people with trauma histories in particular, mindfulness practices that direct sustained attention inward can sometimes increase distress rather than reduce it activating difficult memories, overwhelming the capacity to stay present, or triggering dissociation. Trauma-sensitive adaptations exist, but standard mindfulness protocols are not always appropriate for everyone.
What mindfulness is doing in the brain
One of the reasons the mindfulness evidence base is taken seriously by researchers is the convergence between psychological outcomes and neuroimaging findings.
Studies using fMRI and other neuroimaging methods have found that regular mindfulness practice is associated with structural and functional changes in several brain regions. The amygdala the threat-detection region involved in fear and stress responses shows reduced reactivity and, in long-term practitioners, reduced grey matter volume in ways associated with lower stress reactivity. The prefrontal cortex, associated with executive function, attention regulation, and the modulation of emotional responses, shows increased activity and connectivity. The default mode network the brain’s “resting state” network, associated with mind-wandering, rumination, and self-referential thought shows reduced activity during mindfulness practice.
This last finding is particularly relevant for depression and anxiety, where ruminative thinking the tendency to get caught in repetitive, self-critical or worry-based thought loops is a central maintaining factor. Mindfulness practice appears to reduce the pull of this ruminative mode, not by suppressing the thoughts, but by strengthening the capacity to notice them and redirect attention.
It is worth noting that neuroimaging research in this area has its own methodological limitations small samples, variability in practice protocols, and the difficulty of drawing causal conclusions from correlational data. The convergence with psychological outcome data is encouraging, but the neurological story is still being written.
What the critics get right
The enthusiasm for mindfulness in clinical and corporate settings has attracted substantive criticism, and some of it is well-founded.
The evidence quality is uneven. While some areas of the mindfulness research base particularly MBCT for depression involve well-designed randomised controlled trials with active control conditions, much of the broader literature involves lower-quality designs: no active control, high dropout rates, poorly defined interventions, and inadequate follow-up periods. Meta-analyses that include all available studies tend to produce more impressive effect sizes than those restricted to higher-quality trials. The headline figures sometimes reflect the literature as a whole rather than its most rigorous subset.
The individualisation of what are often structural problems. This is the most important systemic critique. When mindfulness is offered as a solution to workplace burnout, it addresses the individual’s response to unsustainable conditions without addressing the conditions themselves. A worker taught to breathe through their anxiety about an impossible workload is not being helped they are being managed. The use of mindfulness as a corporate wellness tool, in contexts where it substitutes for structural change, has been critiqued by researchers including Ronald Purser, whose book McMindfulness makes this argument at length.
Adverse effects are underreported. The assumption that mindfulness is uniformly safe is not supported by the literature. A growing body of research, including work by Willoughby Britton, documents adverse experiences associated with intensive mindfulness practice including anxiety, depersonalisation, and in some cases the emergence of significant psychological difficulty. These experiences are more common in intensive retreat settings than in standard clinical programmes, but they exist, and they are discussed less openly than the evidence warrants.
What this means practically
Mindfulness is a genuinely useful tool well-evidenced for specific presentations, neurologically plausible, and accessible in a way that many interventions are not. For people with recurrent depression, anxiety, or stress-related difficulties, it is worth taking seriously.
It is not a universal solution. It requires learning and consistent practice to develop the skills that produce its benefits a five-minute app session is not equivalent to an eight-week structured programme. It is not suitable for everyone, particularly without adaptation for people with trauma histories. And it works best as part of a broader approach to psychological wellbeing rather than as a standalone fix.
The version of mindfulness that the research supports is considerably more demanding and more specific than the version sold on app stores. It involves learning to sit with difficult experience rather than escaping it which is a skill that takes time, support, and often guidance to develop.
If you are curious about whether a mindfulness-based approach might be useful for your specific situation, it is worth discussing with a qualified practitioner rather than simply downloading an app and hoping for the best.
Further reading
- Kabat-Zinn, J. (1990). Full Catastrophe Living. Delacorte Press.
- Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2002). Mindfulness-Based Cognitive Therapy for Depression. Guilford Press.
- Kuyken, W., et al. (2016). Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse. JAMA Internal Medicine, 176(9), 1231–1238.
- Purser, R. (2019). McMindfulness: How Mindfulness Became the New Capitalist Spirituality. Repeater Books.
- Britton, W. B. (2019). Can mindfulness be too much of a good thing? Current Opinion in Psychology, 28, 159–165.
Leave a Reply